ColiseoHead-to-Head Startup Ranking & Discovery
A
Arpeggio Bio is a pioneering pharmaceutical company that develops drugs targeting transcription factors using AI and high-throughput RNA-sequencing. With $20M in venture funding, we've targeted "undruggable" proteins like NRF2, TEAD, and GPX4 where our lead program is rapidly progressing towards a DC for the treatment of IO-resistant melanoma. With partnerships with J&J and FORMA, we've validated our platform in rare disease and inflammation with a significant Phase I success.
Founded
2019
Headquarters
Boulder, CO, USA
Team size
11–50
Stage
Early-stage
📊 Coliseo ratings
🏆 Overall 1474 Elo
Total matchups0
⚔️ Vote on today's matchups →Ratings are live Elo scores from head-to-head crowd votes — opinion, not fact or financial advice. How it works →